找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Colorectal Cancer Liver Metastases; A Comprehensive Guid Mauro Monteiro Correia,Michael A. Choti,Go Wakabay Book 2020 Springer Nature Switz

[復(fù)制鏈接]
樓主: 巡洋
41#
發(fā)表于 2025-3-28 16:31:34 | 只看該作者
Simulation and Synthesis in Medical Imaginggimen. There are no accepted predictive biomarkers to guide personalisation of therapy, and patient selection is based upon prognostic rather than predictive criteria. In this chapter we review the evidence for and against NACT, explore the role of biological therapies and provide a summary of current international guidelines.
42#
發(fā)表于 2025-3-28 19:33:59 | 只看該作者
The Biology of Colorectal Liver Metastases, epigenetic, transcriptional, and cellular interactions in the native and host microenvironments is in its initial stages. In this chapter, the stages of colorectal cancer liver metastasis are presented and highlighted by our current mechanistic understanding of metastasis biology.
43#
發(fā)表于 2025-3-29 00:47:41 | 只看該作者
44#
發(fā)表于 2025-3-29 04:30:33 | 只看該作者
Neoadjuvant Chemotherapy for Resectable Colorectal Cancer Liver Metastases: Indications and Resultsgimen. There are no accepted predictive biomarkers to guide personalisation of therapy, and patient selection is based upon prognostic rather than predictive criteria. In this chapter we review the evidence for and against NACT, explore the role of biological therapies and provide a summary of current international guidelines.
45#
發(fā)表于 2025-3-29 09:45:10 | 只看該作者
Multidisciplinary Team (MDT) and the Management of Colorectal Cancer Liver Metastases,perative care, it has been the implementation of dedicated multidisciplinary teams (MDTs) that has made a difference toward better care. This chapter addresses the impact of MDT in the management of colorectal liver metastases.
46#
發(fā)表于 2025-3-29 14:30:16 | 只看該作者
47#
發(fā)表于 2025-3-29 16:16:28 | 只看該作者
https://doi.org/10.1007/978-3-319-71637-4llow-up after the treatment of the primary. This diagnosis is based in clinical, laboratory, and radiological studies. This chapter will address the different circumstances of the diagnosis and the role of each of the present diagnostic tools.
48#
發(fā)表于 2025-3-29 20:37:17 | 只看該作者
Barbara Flach,Maxim Makhinya,Orcun Gokselor. Yet, more recent studies have challenged the oncologic impact of close or microscopically positive (R1) resection. This is particularly important to understand, as this is one factor which is potentially under the control of the surgeon.
49#
發(fā)表于 2025-3-30 02:17:24 | 只看該作者
Simulation and Synthesis in Medical Imagingtes among patients with CRLM are warranted. Resectability of CRLM should be defined along three domains: from a medical standpoint, an oncologic standpoint, and finally a technical standpoint. Adherence to a stepwise protocol for preoperative evaluation of patients with CRLM is critical to ensure proper patient selection and to optimize outcomes.
50#
發(fā)表于 2025-3-30 07:40:11 | 只看該作者
Transfer Learning in Optical Microscopysary to understand PVE indication and FLR evaluation. In this chapter, we summarize how to evaluate FLR from anatomical, physiological, and kinetic aspects and we describe the effects and problems of PVE referring to previously published papers.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 12:14
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
柳河县| 稷山县| 盱眙县| 靖江市| 通城县| 东阿县| 洛宁县| 峨山| 杭锦后旗| 宁津县| 加查县| 堆龙德庆县| 富平县| 鲁甸县| 珠海市| 江油市| 句容市| 仁寿县| 岳西县| 鸡东县| 工布江达县| 鸡西市| 榕江县| 依兰县| 吐鲁番市| 香格里拉县| 娄底市| 肥乡县| 佛山市| 渑池县| 庆阳市| 乐清市| 南陵县| 盐津县| 藁城市| 万州区| 本溪市| 宣威市| 肥东县| 宁晋县| 兴城市|